Detalhe da pesquisa
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36071165
2.
Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
J Med Genet
; 61(2): 158-162, 2024 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37775264
3.
The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination.
Nucleic Acids Res
; 2023 Dec 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38142462
4.
Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.
Cancer
; 2024 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38824658
5.
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Br J Cancer
; 130(4): 613-619, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38182687
6.
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Am J Hum Genet
; 108(10): 1907-1923, 2021 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34597585
7.
Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research.
Future Oncol
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38722139
8.
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Mol Cancer
; 22(1): 176, 2023 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37924050
9.
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Mol Cancer
; 22(1): 178, 2023 11 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37932736
10.
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecol Oncol
; 171: 106-113, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36868112
11.
Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37511329
12.
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I.
Hum Mutat
; 43(3): 316-327, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34882875
13.
Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.
BMC Cancer
; 22(1): 759, 2022 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35820813
14.
Molecular pathology testing for non-small cell lung cancer: an observational study of elements currently present in request forms and result reports and the opinion of different stakeholders.
BMC Cancer
; 22(1): 736, 2022 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35794532
15.
Co-occurrence of germline BRCA1 and CDH1 pathogenic variants.
J Med Genet
; 58(6): 357-361, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32576655
16.
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
Hum Mutat
; 41(1): 7-16, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31553104
17.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
BMC Cancer
; 20(1): 366, 2020 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32357863
18.
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
Eur Radiol
; 30(9): 5021-5028, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32323012
19.
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Nucleic Acids Res
; 46(15): 7913-7923, 2018 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29750258
20.
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases.
Ann Diagn Pathol
; 46: 151522, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32442860